In vitro experiments demonstrated that CAR-T cells can specifically eliminate TM4SF1-positive tumor cell lines, while in vivo studies revealed that these modified immune cells significantly inhibited SKOV3-derived tumor growth. Here, TM4SF1 is linked to neoplasm.